Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.

@article{Courtney2004EffectOF,
  title={Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.},
  author={R. Courtney and D. Wexler and E. Radwanski and J. Lim and M. Laughlin},
  journal={British journal of clinical pharmacology},
  year={2004},
  volume={57 2},
  pages={
          218-22
        }
}
  • R. Courtney, D. Wexler, +2 authors M. Laughlin
  • Published 2004
  • Medicine
  • British journal of clinical pharmacology
  • AIMS This randomized, crossover, single-dose study evaluated the relative oral bioavailability of posaconazole suspension and coprecipitate tablet formulations. Additionally, the study determined whether systemic exposure to posaconazole was affected by prandial status or by the fat content of a meal. METHODS This was a randomized, open-label, four-way crossover, single-dose study in 20 healthy men. Posaconazole pharmacokinetics were evaluated over 72 h following a single oral dose of… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Effect of Varying Amounts of a Liquid Nutritional Supplement on the Pharmacokinetics of Posaconazole in Healthy Volunteers
    • 45
    • Highly Influenced
    • Open Access
    Effect of a High-Fat Meal on the Pharmacokinetics of 300-Milligram Posaconazole in a Solid Oral Tablet Formulation
    • 26
    • Highly Influenced
    • Open Access
    Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers
    • 259
    • Highly Influenced
    • Open Access
    Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men
    • 131
    • Open Access
    Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers
    • 29
    • Open Access

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 14 REFERENCES
    Effects of Food on Clinical Pharmacokinetics
    • 293